Hermann Luebbert's most recent trade in Biofrontera Inc was a trade of 137,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 137,500 | 0 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 137,500 | 290,211 | - | - | Common Stock | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 125,000 | 125,000 | - | - | Employee stock option (right to buy) | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 125,000 | 125,000 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 137,500 | 152,711 | - | - | Common Stock | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 137,500 | 137,500 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 125,000 | 125,000 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 125,000 | 125,000 | - | - | Employee stock option (right to buy) | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 275,000 | 275,000 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 275,000 | 290,211 | - | - | Employee stock option (right to buy) | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Exec. Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2024 | 4,771 | 15,211 | - | - | Common Stock | |
| Biofrontera Inc | Hermann Luebbert | Director, CEO & Exec. Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2024 | 4,771 | 0 | - | - | Restricted Stock Units | |
| Biofrontera Inc | Hermann Luebbert | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 95,420 | 208,799 | - | - | Common Stock | |
| Biofrontera Inc | Hermann Luebbert | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 95,420 | 95,420 | - | - | Restricted Stock Units |